Pendapatan reged perusahaan Catalyst Pharma (CPRX)
Catalyst Pharmaceuticals is recruiting leading clinicians to combat rare brain pathologies. The company aims for dominance in the orphan segment through the acquisition of new assets. Sales revenue for the company on GURU.Markets reflects business dynamics where 0.60 serves as the base parameter value. Stability of indicators is ensured through the complete outsourcing of production according to GMP standards.
Rincian metrik komprehensif lan analitis Catalyst Pharmaceuticals, Inc. (CPRX)
- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- data kapitalisasi buku:
- statistik kawajiban utang lan likuiditas:
Utang Agregat marang Ekuitas Catalyst Pharmaceuticals|CPRX - Utang jangka dawa marang modal|Rasio tanggungan utang jangka cendhak marang modal Catalyst Pharma|CPRX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Catalyst Pharmaceuticals, Inc.|CPRX - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Catalyst Pharmaceuticals|Indikator likuiditas cepet catalystpharma.com
- informasi bathi lan kelipatan valuasi:
CPRX - Bathi resik|Proyeksi bathi mangsa ngarep Catalyst Pharmaceuticals|CPRX - Pangali P/E|Prakiraan rega marang bathi catalystpharma.com|CPRX - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Catalyst Pharmaceuticals, Inc.|CPRX - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Catalyst Pharmaceuticals|CPRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan catalystpharma.com|CPRX - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Catalyst Pharmaceuticals
- rincian pendapatan lan dodolan emiten:
Ringkesan analisis perusahaan:CPRX, Catalyst Corp
Automation of drug synthesis for rare diseases at Catalyst Pharmaceuticals (CPRX) is accelerating development, yet commercial success remains contingent upon passing rigorous clinical trials. By analyzing the company's overall sales, an investor can monitor daily revenue inflows, allowing for the identification of signs of business stagnation or overheating by comparing current income with historical trends to avoid overpaying for a slowing asset.
Analisis perusahaan pesaing
Total pendapatan perusahaan Biogen Idec BIIB|Pendapatan perusahaan Neurocrine Biosciences (NBIX)|Pendapatan reged perusahaan regencellbioscience.com|Axsome Therapeutics, Inc. - Dodolan perusahaan|Total dodolan perusahaan ACAD (ACADIA Pharma)|XENE: Dodolan perusahaan|Pendapatan dodolan perusahaan VKTX (Viking Therapeutics Corp)|Supernus Pharmaceuticals (SUPN) - Pendapatan perusahaan|Pendapatan tahunan perusahaan DNLI (denalitherapeutics.com)|HRMY (Harmony Biosciences Holdings, Inc.) - Pendapatan lan volume dodolan|BHVN: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan AMLX|Pendapatan lan volume dodolan Trevi Corp (TRVI)|Pendapatan perusahaan Praxis Precision Medicines PRAX|Pendapatan dodolan perusahaan AVXL|CBLL - Pendapatan perusahaan|Prothena Corporation plc (PRTA) - Dodolan perusahaan|ALEC: Pendapatan lan volume dodolan|Annexon Biosciences Inc. (ANNX) - Pendapatan lan volume dodolan|OMER (Omeros Corp) - Pendapatan lan volume dodolan|Dodolan perusahaan neurogene.com (NGNE)|Pendapatan lan volume dodolan ACIU|VYGR - Total pendapatan perusahaan|Neumora Therapeutics Inc - Dodolan perusahaan|Pendapatan lan volume dodolan Scilex Holding Company, Inc. SCLX|TVGN: Dodolan perusahaan|Alpha Cognition - Total dodolan perusahaan|CGTX: Pendapatan lan volume dodolan|IKT - Pendapatan reged perusahaan|SAVA (Cassava) - Pendapatan lan volume dodolan|Dodolan perusahaan Assertio Therapeutics (ASRT)|Pendapatan lan volume dodolan COYA|Pendapatan lan volume dodolan vistagen.com (VTGN)|Pendapatan perusahaan Ovid Therapeutics OVID|Acumen Pharmaceuticals Inc. - Pendapatan perusahaan|CRVO - Pendapatan perusahaan|Pendapatan reged perusahaan Alterity Therapeutics ATHE|CLNN: Pendapatan lan volume dodolan|Dodolan perusahaan PepGen|Pendapatan perusahaan Jupiter Neurosciences Inc|Relmada Therapeutics Inc - Pendapatan tahunan perusahaan|Pendapatan perusahaan Annovis Bio Corp (ANVS)|GRCE (gracetx.com) - Pendapatan dodolan perusahaan|Firefly Neuroscience, Inc - Dodolan perusahaan|KLTO: Volume dodolan perusahaan|NRSN - Pendapatan perusahaan|RVPH (Reviva Pharmaceuticals Holdings Inc.) - Volume dodolan perusahaan|MTVA: Pendapatan lan volume dodolan|Total pendapatan perusahaan NeurAxis Inc (NRXS)|Dodolan perusahaan HSDT|Pendapatan lan volume dodolan Passage Bio Corp|Pendapatan perusahaan Neuphoria Therapeutics Inc. (NEUP)|NERV (Minerva Neurosciences Inc) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Athira ATHA|Addex (ADXN) - Total pendapatan perusahaan|Alzamend - Pendapatan lan volume dodolan|Cyclerion Therapeutics (CYCN) - Dodolan perusahaan|PTIX: Pendapatan lan volume dodolan|Pasithea Therapeutics Corp. (KTTA) - Pendapatan lan volume dodolan|Dodolan perusahaan CRGT|ATXI (Avenue Therapeutics Inc) - Total dodolan perusahaan|Pendapatan lan volume dodolan BCLI|Pendapatan lan volume dodolan caratherapeutics.com (CARA)|Pendapatan perusahaan Chromocell Therapeutics Corp. CHRO|Eliem Therapeutics, Inc. - Pendapatan perusahaan|ITCI: Dodolan perusahaan|Total pendapatan perusahaan Longboard|Marinus Pharmaceuticals (MRNS) - Pendapatan perusahaan|NKGN - Pendapatan reged perusahaan|Dodolan perusahaan NRBO|SAGE (Sage Therapeutics Inc.) - Total dodolan perusahaan|Dodolan perusahaan SNPX (Neurotrope)|TRVN (Trevena Inc) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Vigil Neuroscience, Inc. VIGL|WENA (Anew Medical Inc.) - Pendapatan tahunan perusahaan|Cerevel Therapeutics, Inc. - Pendapatan lan volume dodolan
